Canadian Solar And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Canadian Solar (CSIQ), Harmony Biosciences Holdings (HRMY), Itau Unibanco (ITUB) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Canadian Solar (CSIQ)

34.5% sales growth and 18.21% return on equity

Canadian Solar Inc., together with its subsidiaries, designs, develops, manufactures, and sells solar ingots, wafers, cells, modules, and other solar power products. The company operates through two segments, Module and System Solutions (MSS), and Energy. The MSS segment engages in the design, development, manufacture, and sale of a range of solar power products, including standard solar modules, specialty solar products, and solar system kits that are a ready-to-install packages comprising inverters, racking systems, and other accessories. It also provides engineering, procurement, and construction; and operation and maintenance (O&M) services. This segment's energy solution products include solar inverters and energy storage systems for utility, commercial, residential, and specialty product applications. Its O&M services include inspections, repair, and replacement of plant equipment; and site management and administrative support services for solar power projects. The Energy segment engages in the development and sale of solar power projects; and operation of solar power plants and sale of electricity. As of January 31, 2020, this segment had a fleet of solar power plants in operation with an aggregate capacity of approximately 880.2 MWp. The company's primary customers include distributors, system integrators, project developers, and installers/EPC companies. Canadian Solar Inc. sells its products primarily under its Canadian Solar brand name; and on an OEM basis. It has operations in North America, South America, Europe, South Africa, the Middle East, Australia, Asia, and internationally. The company was founded in 2001 and is headquartered in Guelph, Canada.

Earnings Per Share

As for profitability, Canadian Solar has a trailing twelve months EPS of $5.72.

PE Ratio

Canadian Solar has a trailing twelve months price to earnings ratio of 3.9. Meaning, the purchaser of the share is investing $3.9 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.21%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 27.7% and positive 32.4% for the next.

Yearly Top and Bottom Value

Canadian Solar’s stock is valued at $22.32 at 20:22 EST, way under its 52-week high of $45.29 and above its 52-week low of $21.08.

2. Harmony Biosciences Holdings (HRMY)

27.4% sales growth and 54.73% return on equity

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy in the United States. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

Earnings Per Share

As for profitability, Harmony Biosciences Holdings has a trailing twelve months EPS of $2.93.

PE Ratio

Harmony Biosciences Holdings has a trailing twelve months price to earnings ratio of 6.87. Meaning, the purchaser of the share is investing $6.87 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 54.73%.

3. Itau Unibanco (ITUB)

25.6% sales growth and 18.3% return on equity

Itaú Unibanco Holding S.A. offers a range of financial products and services to individuals and corporate customers in Brazil and internationally. The company operates through three segments: Retail Banking, Wholesale Banking, and Activities with the Market + Corporation. It offers current account; loans; credit and debit cards; investment and commercial banking services; real estate lending services; financing and investment services; economic, financial and brokerage advisory; and leasing and foreign exchange services. The company also provides property and casualty insurance products covering loss, damage, or liabilities for assets or persons, as well as life insurance products covering death and personal accident. It serves retail customers, account and non-account holders, individuals and legal entities, high income clients, microenterprises, and small companies, as well as middle-market companies and high net worth clients. The company was formerly known as Itaú Unibanco Banco Múltiplo S.A. and changed its name to Itaú Unibanco Holding S.A. in April 2009. The company was incorporated in 1924 and is headquartered in São Paulo, Brazil. Itaú Unibanco Holding S.A. operates as a subsidiary of IUPAR – Itaú Unibanco Participações S.A.

Earnings Per Share

As for profitability, Itau Unibanco has a trailing twelve months EPS of $0.64.

PE Ratio

Itau Unibanco has a trailing twelve months price to earnings ratio of 8.52. Meaning, the purchaser of the share is investing $8.52 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.3%.

Yearly Top and Bottom Value

Itau Unibanco’s stock is valued at $5.45 at 20:22 EST, way below its 52-week high of $6.15 and way higher than its 52-week low of $4.21.

4. International General Insurance Holdings Ltd. (IGIC)

20.5% sales growth and 26.86% return on equity

International General Insurance Holdings Ltd. provides specialty insurance and reinsurance solutions worldwide. The company operates through three segments: Specialty Long-tail, Specialty Short-tail, and Reinsurance segments. It offers a portfolio of specialty lines insurance products and services for energy, property, construction and engineering, ports and terminals, general aviation, political violence, casualty, financial institutions, marine liability, and treaty reinsurance. The company was founded in 2001 and is based in Amman, Jordan.

Earnings Per Share

As for profitability, International General Insurance Holdings Ltd. has a trailing twelve months EPS of $2.33.

PE Ratio

International General Insurance Holdings Ltd. has a trailing twelve months price to earnings ratio of 4.67. Meaning, the purchaser of the share is investing $4.67 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.86%.

5. CoStar Group (CSGP)

12.4% sales growth and 5.92% return on equity

CoStar Group, Inc. provides information, analytics, and online marketplace services to the commercial real estate, hospitality, residential, and related professionals industries in the United States, Canada, Europe, the Asia Pacific, and Latin America. The company offers CoStar Property that provides inventory of office, industrial, retail, multifamily, hospitality, and student housing properties and land; CoStar Sales, a robust database of comparable commercial real estate sales transactions; CoStar Market Analytics to view and report on aggregated market and submarket trends; and CoStar Tenant, an online business-to-business prospecting and analytical tool that provides tenant information. It also provides Leasing, a tool to capture, manage, and maintain lease data; CoStar Lease Analysis; Public Record, a searchable database of commercially zoned parcels; CoStar Real Estate Manager, a real estate lease administration, portfolio management, and lease accounting compliance software solution; and CoStar Risk Analytics and CoStar Investment. In addition, it offers apartment marketing sites, such as ApartmentFinder.com, ForRent.com, ApartmentHomeLiving.com, WestsideRentals.com, AFTER55.com, CorporateHousing.com, ForRentUniversity.com, Apartamentos.com, and Off Campus Partners; LoopNet Premium Lister; LoopNet Diamond, Platinum, and Gold Ads; LandsofAmerica.com, LandAndFarm.com, and LandWatch.com for rural land for-sale; BizBuySell.com, BizQuest.com, and FindaFranchise.com for operating businesses and franchises for-sale; Ten-X, an online auction platform for commercial real estate; and HomeSnap, an online and mobile software platform, as well as Homes.com, a homes for sale listings site. The company was founded in 1987 and is headquartered in Washington, the District of Columbia.

Earnings Per Share

As for profitability, CoStar Group has a trailing twelve months EPS of $0.99.

PE Ratio

CoStar Group has a trailing twelve months price to earnings ratio of 71.44. Meaning, the purchaser of the share is investing $71.44 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.92%.

Previous days news about CoStar Group(CSGP)

  • According to MarketWatch on Wednesday, 25 October, "Shares of CoStar Group Inc. tumbled 7.7% toward a six-month low in morning trading Wednesday, after the real estate marketplace provider came up short on third-quarter revenue and trimmed its full-year outlook, amid "one of the worst property markets in decades." The stock was currently the fourth-worst performer in the S&P 500 on the day. "

6. Globus Medical (GMED)

5.8% sales growth and 11.09% return on equity

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Earnings Per Share

As for profitability, Globus Medical has a trailing twelve months EPS of $2.05.

PE Ratio

Globus Medical has a trailing twelve months price to earnings ratio of 26.02. Meaning, the purchaser of the share is investing $26.02 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.09%.

Yearly Top and Bottom Value

Globus Medical’s stock is valued at $53.35 at 20:22 EST, way under its 52-week high of $80.04 and above its 52-week low of $48.78.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.6%, now sitting on 1.1B for the twelve trailing months.

Previous days news about Globus Medical(GMED)

  • According to Zacks on Friday, 27 October, "Among the completed deals of the third quarter, Globus Medical closed the $3.1 billion deal to acquire spine technology company, NuVasive."

Leave a Reply

Your email address will not be published. Required fields are marked *